Pharmaceutical News

RSS

Successor to Vioxx fails to quell concerns

When drug company Merck revealed the the results of a study this week over it's successor to Vioxx, the new arthritis drug Arcoxia, it did little to quell concerns about both the use and the safety of the new drug.

15 Nov 2006

MSF, Oxfam call on wealthy nations to adhere to WTO guidelines to ensure drug access in developing countries

Medecins Sans Frontieres and Oxfam on Tuesday called on developed nations to adhere to the World Trade Organization's Agreement on Trade-Related Aspects of Intellectual Property Rights to ensure universal access to antiretroviral drugs in developing countries, the AP/International Herald Tribune reports (Higgins, AP/International Herald Tribune, 11/14).

14 Nov 2006

Tamiflu to carry warning about abnormal behaviour

The Food and Drug Administration in the U.S. (FDA) is recommending that patients who take Tamiflu be closely monitored for signs of abnormal behaviour.

14 Nov 2006

Bush Administration says it opposes Democrats' plan to allow Government to negotiate Medicare drug prices

The Bush administration will oppose any attempts by congressional Democrats to pass legislation that would authorize the government to negotiate with pharmaceutical companies under the Medicare prescription drug benefit, according to HHS Secretary Mike Leavitt, the New York Times reports.

13 Nov 2006

FDA should return to 'science-based' agency

Congress this month likely will consider a bill to reform FDA, "but the legislation lacks the vision and depth needed for a real return to a science-based FDA," Susan Wood, a research professor for the Project on Scientific Knowledge and Public Policy at the George Washington University School of Public Health and Health Services and former assistant commissioner for women's health at FDA, writes in a Boston Globe opinion piece.

13 Nov 2006

Drug industry concerned about California Law allowing State to seek drug discounts

A new California law set to take effect in January 2007 "provides a glimpse of the type of government price controls the drug industry fears," the Boston Globe reports.

13 Nov 2006

Millions of bottles of a common pain killer recalled

The Food and Drug Administration (FDA) in the U.S. has alerted consumers that a drug company in Michigan has recalled millions of bottles of a commonly used painkiller because the pills may contain pieces of metal.

13 Nov 2006

Recall of Strength Store-brand Acetaminophen caplets

The U.S. Food and Drug Administration (FDA) is alerting the public to a voluntary recall being conducted by Perrigo Company (Perrigo) of Allegan, Michigan for 383 lots of acetaminophen 500mg caplets manufactured and distributed under various store-brands as a result of small metal fragments found in a small number of these caplets.

13 Nov 2006

Majority of Medicare beneficiaries satisfied with prescription drug plans

Three-fourths of Medicare beneficiaries enrolled in the prescription drug benefit are satisfied with their plans, according to a recent Wall Street Journal Online/Harris Interactive poll, Wall Street Journal Online reports.

8 Nov 2006

Bionomics delivers on milestones for cancer, anxiety and multiple sclerosis programs

Australian drug discovery company Bionomics Limited today updated shareholders at its Annual General Meeting on the recent progress of its anti-cancer drug BNC105 and drug discovery programs in anxiety and Multiple Sclerosis.

8 Nov 2006

Problems with billing for Medicare prescription drug benefit premiums persist

About 50,000 of the 4.7 million Medicare beneficiaries who opted to have their Medicare prescription drug benefit premiums automatically withdrawn from their Social Security checks still are having incorrect amounts deducted, CMS officials said, USA Today reports.

8 Nov 2006

New initiative to combat corruption in medicines procurement

Huge amounts of money - up to $50 billion - are spent every year on pharmaceutical products, a market so large that it is extremely vulnerable to corruption. Recent estimates have shown that as much as 25% of medicines which are procured can be lost to fraud, bribery and other corrupt practices.

30 Oct 2006

GSK about to sign another big bird flu deal

Europe's largest drug maker GlaxoSmithKline is said to be about to sign another deal to provide tens of millions of doses of it's experimental H5N1 vaccine for humans.

30 Oct 2006

Big pharma contributes millions to Republican congressional campaigns in close races

The Wall Street Journal on Wednesday examined how pharmaceutical companies are "pouring millions of dollars" into congressional campaigns in close races, "giving some Republicans a financial edge."

26 Oct 2006

Wal-Mart expands generic prescription drug discount program

Wal-Mart Stores on Thursday announced plans to expand a generic prescription drug discount program introduced last month to 12 additional states, the AP/Houston Chronicle reports (AP/Houston Chronicle, 10/26).

26 Oct 2006

FDA approves Tyzeka for the treatment of adults with chronic hepatitis B

The Food and Drug Administration (FDA) has approved Tyzeka (telbivudine) for the treatment of adults with chronic hepatitis B (HBV), a serious viral infection that attacks the liver and can cause lifelong infection, scarring of the liver (cirrhosis), and eventually liver cancer, liver failure, and death.

26 Oct 2006

Pharmaceutical News

Successor to Vioxx fails to quell concerns

MSF, Oxfam call on wealthy nations to adhere to WTO guidelines to ensure drug access in developing countries

Tamiflu to carry warning about abnormal behaviour

Bush Administration says it opposes Democrats' plan to allow Government to negotiate Medicare drug prices

FDA should return to 'science-based' agency

Drug industry concerned about California Law allowing State to seek drug discounts

Millions of bottles of a common pain killer recalled

Recall of Strength Store-brand Acetaminophen caplets

Majority of Medicare beneficiaries satisfied with prescription drug plans

Bionomics delivers on milestones for cancer, anxiety and multiple sclerosis programs

Problems with billing for Medicare prescription drug benefit premiums persist

New initiative to combat corruption in medicines procurement

GSK about to sign another big bird flu deal

Big pharma contributes millions to Republican congressional campaigns in close races

Wal-Mart expands generic prescription drug discount program

FDA approves Tyzeka for the treatment of adults with chronic hepatitis B

Shingles vaccine for seniors gets the green light

Doctors warned that commonly used painkillers linked to increased risk of heart attacks

Bristol-Myers Squibb receives FDA approval for new formulation of antiretroviral Reyataz

Use of subcutaneous injections of Epogen for dialysis patients could save Medicare $537 million annually

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News